How much funding has Natera raised?

Natera has raised $310.1M in total funding, most recently a Series E round.

Who are Natera's investors?

Natera's investors include Capital Research and Management, Claremont Creek Ventures, OrbiMed, Franklin Templeton, Jennison Associates, RA Capital Management.

Where is Natera headquartered?

Natera is headquartered in San Carlos, California, United States.

What industry is Natera in?

Natera operates in Diagnostics, Genomics, Healthcare.

How many employees does Natera have?

Natera has 5001-10000 employees.

Natera

IPO

A global leader in cfDNA testing

Public · San Carlos, United States · Founded 2004 · $310.1M raised

Diagnostics

Genomics

Healthcare

Headquarters: San Carlos, California
Employees: 5001–10000
Founded: 2004
Business Model: B2B
Website: natera.com

Total Funding: $310.1M
Last Round: $200.0M Series EJul 2019
Rounds: 4
Type: Public

About

Natera is a global leader in cell-free DNA (cfDNA) testing dedicated to oncology, women's health, and organ health. The company's tests — including Signatera for cancer MRD detection, Panorama for prenatal screening, and Prospera for transplant monitoring — are backed by over 400 peer-reviewed publications and processed in CLIA-certified, CAP-accredited laboratories.

Summary

Natera is a Diagnostics company based in San Carlos, United States, founded in 2004. It has raised $310.1M in total across 4 rounds, most recently a $200.0M Series E round in Jul 2019. Investors include Capital Research and Management, Claremont Creek Ventures and OrbiMed.

LinkedIn X (Twitter)